Evidence map›Paper›PMID 32057797›Full record

ArticleExperimental neurology2020

Bioenergetic restoration and neuroprotection after therapeutic targeting of mitoNEET: New mechanism of pioglitazone following traumatic brain injury.

Heather M Yonutas, W Brad Hubbard, Jignesh D Pandya, Hemendra J Vekaria, Werner J Geldenhuys, Patrick G Sullivan

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Suppression ofmicroPublication biology · 2025
    Article
  10. mTOR inhibition enhances synaptic and mitochondrial function in Alzheimer's disease in an APOE genotype-dependent manner.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Synergistic Effect ofNutrients · 2023
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Heather M YonutasSpinal Cord & Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA; Department of Neuroscience, University of Kentucky, Lexington, KY 40536, USA. Electronic address: heather.yonutas@yahoo.com.
W Brad HubbardSpinal Cord & Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA; Department of Neuroscience, University of Kentucky, Lexington, KY 40536, USA; Lexington VA Healthcare System, Lexington, KY 40502, USA. Electronic address: bradhubbard@uky.edu.
Jignesh D PandyaSpinal Cord & Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA; Currently Research Biologist, Brain Trauma Neuroprotection and Neurorestoration (BTNN) Branch, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD 20910, USA. Electronic address: jignesh.d.pandya.civ@mail.mil.
Hemendra J VekariaSpinal Cord & Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA; Department of Neuroscience, University of Kentucky, Lexington, KY 40536, USA. Electronic address: hemendravekaria@uky.edu.
Werner J GeldenhuysDepartment of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown 26501, USA. Electronic address: werner.geldenhuys@hsc.wvu.edu.
Patrick G SullivanSpinal Cord & Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA; Department of Neuroscience, University of Kentucky, Lexington, KY 40536, USA; Lexington VA Healthcare System, Lexington, KY 40502, USA. Electronic address: patsullivan@uky.edu.
University of Kentucky · USUniversity of Kentucky HealthCare · USWest Virginia University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Anne Courtney DeVries · 2012 to 2026
$81.0M
Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
West Virginia University Stroke COBREP20GM109098 · NIGMS · WEST VIRGINIA UNIVERSITY · PI DEVRIES, ANNE COURTNEY · 2014 to 2024
$24.5M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Essential Siemens Prisma Fit Upgrade for the University of Kentucky 3T Research ScannerS10OD023573 · OD · UNIVERSITY OF KENTUCKY · PI SMITH, CHARLES DENNIS · 2017 to 2017
$813k
Investigating the Role of Pioglitazone, mitoNEET and Mitochondria following TBIF31NS086395 · NINDS · UNIVERSITY OF KENTUCKY · PI YONUTAS, HEATHER · 2014 to 2015
$48k
Targeting mitostasis via activation of mitochondrial biogenesis after TBII01BX003405 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI SULLIVAN, PATRICK G · 2017 to 2025
–
BLRD VA I01 BX003405NCATS NIH HHS UL1 TR000117NCATS NIH HHS UL1 TR001998NIGMS NIH HHS P20 GM109098NIGMS NIH HHS U54 GM104942NIH HHS S10 OD023573NINDS NIH HHS F31 NS086395
6 · The paper itself

Abstract

Mitochondrial dysfunction is a pivotal event in many neurodegenerative disease states including traumatic brain injury (TBI) and spinal cord injury (SCI). One possible mechanism driving mitochondrial dysfunction is glutamate excitotoxicity leading to Ca

Indexed as

AnimalsBrain Injuries, TraumaticDisease Models, AnimalEnergy MetabolismIron-Binding ProteinsMaleMembrane ProteinsMiceMice, KnockoutMitochondriaNeuroprotectionNeuroprotective AgentsPioglitazoneRatsRats, Sprague-DawleyIron-Binding ProteinsMembrane ProteinsmitoNEET protein, mouseNeuroprotective AgentsPioglitazoneBeam walkCalcium overloadControlled cortical impactMitochondrial bioenergeticsNL-1Novel object recognitionSeahorse

Identifiers

PMID32057797
PMCPMC7089834
OpenAlexW3005974333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.